Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2Penglei Wang, Kangdong Liu, Pan Li et al.|Signal Transduction and Targeted Therapy|2023Cited by 93
Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growthXuechao Jia, Kangdong Liu, Qiong Wu et al.|Journal of Experimental & Clinical Cancer Research|2023Cited by 16
Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targetsDengyun Zhao, Kangdong Liu, Guiliang He et al.|JCI Insight|2024Cited by 12
Additional file 2 of Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growthXuechao Jia, Kangdong Liu, Bingbing Lu et al.|Open MIND|2023Cited by 0
Additional file 1 of Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growthXuechao Jia, Kangdong Liu, Bingbing Lu et al.|Figshare|2023Cited by 0